During November 2017 Clinical Knowledge Summaries were updated in the following areas.
The following topics were all reviewed:
- Benign paroxysmal positional vertigo
- Generalized anxiety disorder
- Irritable bowel syndrome
- Urinary tract infection - children
The majority of topics have undergone reviews and minor restructures.
The most significant changes are in Irritable bowel syndrome and Psoriasis topics. The Irritable bowel syndrome topic has been updated where the recommendations on the diagnosis and management of irritable bowel syndrome have been amended in line with current evidence, including the addition of linaclotide as a drug treatment option. The Psoriasis topic has been updated where recommendations on the diagnosis and management of psoriasis have been amended in line with current evidence, an additional node has been added to the Management section on Specialist investigations and treatment and the section on Topical corticosteroids has been replaced with a link to the CKS topic on Corticosteroids - topical (skin), nose, and eyes.
Action: Clinicians who see patients with any of these conditions may find the new and updated information useful when reviewing current clinical practice.
|« Drug Safety Update - November 2017|